Form 8-K - Current report:
SEC Accession No. 0001641172-25-025274
Filing Date
2025-08-22
Accepted
2025-08-22 17:28:28
Documents
21
Period of Report
2025-08-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 4.01: Changes in Registrant's Certifying Accountant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 59280
2 EX-16.1 ex16-1.htm EX-16.1 957
3 EX-99.1 ex99-1.htm EX-99.1 2197
4 EX-99.2 ex99-2.htm EX-99.2 9710
5 GRAPHIC ex99-1_001.jpg GRAPHIC 656359
6 GRAPHIC ex99-1_002.jpg GRAPHIC 153909
7 GRAPHIC ex99-2_001.jpg GRAPHIC 13194
8 GRAPHIC ex16-1_001.jpg GRAPHIC 233790
  Complete submission text file 0001641172-25-025274.txt   1745913

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ptix-20250807.xsd EX-101.SCH 3795
10 XBRL DEFINITION FILE ptix-20250807_def.xml EX-101.DEF 26654
11 XBRL LABEL FILE ptix-20250807_lab.xml EX-101.LAB 36748
12 XBRL PRESENTATION FILE ptix-20250807_pre.xml EX-101.PRE 25278
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5769
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12555 | Film No.: 251247277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)